Direct to Patient

Direct-to-Patient Program refers to shipment of investigational drugs to patients’ homes for participation in clinical studies.

Mobility and accessibility of patients to clinical trial drugs may sometimes be a challenge. Our Direct-to-Patient Program bridges this gap by delivering investigational drugs to patients’ homes, while ensuring their full confidentiality.